2Aimoguera C, Shibata D, Forrester K, et al. Most human carcinomas of the exocrine pancrine contain mutant K-ras gene, Cell,1988；53:549-554.
3Smit VT HBM, Boot AJM, Smim AMM, et al. Detection of Kras eodon 12 mutations ha pancreatic tissues with OND. Nuct.Acids Res, 1988；16:7773-7782.
4Levi S, Urban-Ispizua A, Gill R, et al, Multiple K-ras condon 12 mutations in chologangicarcinornas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res, 1991；51:3497-3502.
5Kashii T, Mizushima y. Monnos, et al. Gene analysis of K,Hras, p53, and retinoblastoma susceptibility gene in humanlung cancer cell lines by the polymerase chain reaction/single strand conformation polyrnorphism method, J Cancer Res Clin Oncol, 1994；120:143-148.
6Rodenhuis S, S1ebos RJ. Clinical significaneer of ras oncogene activation in human lung cancer. Cancer Res, 1992；52:2665-2669s.
7Qualfe CJ, Pinkezt CA, Orrdtz DM, et aL Pancreatic neoplasia induced by ras expression in acinar cell of transgenic mice, Cell,1987；48:1023-1034.
8Kondo H, Sugano K, Fukayama N, et al. Detection of point mutations in the K-ras ocogene at codon 12 in pure pancteatic juice for diagnosis of pancreatic carcinoma. Cancer, 1994；73:1589-1594.
9Bishop JM, The molecular genetics of cancer, Science, 1987；235:305-309.
